261 related articles for article (PubMed ID: 27253998)
1. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.
Gillis NE; Taber TH; Bolf EL; Beaudet CM; Tomczak JA; White JH; Stein JL; Stein GS; Lian JB; Frietze S; Carr FE
Endocrinology; 2018 Jun; 159(6):2484-2494. PubMed ID: 29750276
[TBL] [Abstract][Full Text] [Related]
3. The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.
Bolf EL; Gillis NE; Barnum MS; Beaudet CM; Yu GY; Tomczak JA; Stein JL; Lian JB; Stein GS; Carr FE
Horm Cancer; 2020 Feb; 11(1):34-41. PubMed ID: 31865591
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Zhang X; Jeyakumar M; Bagchi MK
J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
[TBL] [Abstract][Full Text] [Related]
5. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
[TBL] [Abstract][Full Text] [Related]
7. Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.
Ichijo S; Furuya F; Shimura H; Hayashi Y; Takahashi K; Ohta K; Kobayashi T; Kitamura K
PLoS One; 2014; 9(12):e116252. PubMed ID: 25548921
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.
Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R
Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097
[TBL] [Abstract][Full Text] [Related]
9. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
[TBL] [Abstract][Full Text] [Related]
11. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
Park JW; Zhao L; Willingham MC; Cheng SY
Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
[TBL] [Abstract][Full Text] [Related]
12. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
[TBL] [Abstract][Full Text] [Related]
13. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
[TBL] [Abstract][Full Text] [Related]
14. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
[TBL] [Abstract][Full Text] [Related]
15. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
17. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
[TBL] [Abstract][Full Text] [Related]
18. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
Kato Y; Ying H; Willingham MC; Cheng SY
Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
20. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
